BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11458004)

  • 1. Human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus) ORF50 interacts synergistically with the tat gene product in transactivating the human immunodeficiency virus type 1 LTR.
    Caselli E; Menegazzi P; Bracci A; Galvan M; Cassai E; Di Luca D
    J Gen Virol; 2001 Aug; 82(Pt 8):1965-1970. PubMed ID: 11458004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient expression of human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus) ORF50 enhances HIV-1 replication.
    Caselli E; Galvan M; Cassai E; Di Luca D
    Intervirology; 2003; 46(3):141-9. PubMed ID: 12867751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells.
    Hyun TS; Subramanian C; Cotter MA; Thomas RA; Robertson ES
    J Virol; 2001 Sep; 75(18):8761-71. PubMed ID: 11507221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
    Wakeman BS; Izumiya Y; Speck SH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human herpesvirus 8 (HHV-8) thymidine kinase (TK) TATAA-less promoter by HHV-8 ORF50 gene product is SP1 dependent.
    Zhang L; Chiu J; Lin JC
    DNA Cell Biol; 1998 Sep; 17(9):735-42. PubMed ID: 9778032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human herpesvirus-8 (Kaposi's sarcoma-associated virus) ORF50 increases in vitro cell susceptibility to human immunodeficiency virus type 1 infection.
    Caselli E; Galvan M; Santoni F; Rotola A; Caruso A; Cassai E; Luca DD
    J Gen Virol; 2003 May; 84(Pt 5):1123-1131. PubMed ID: 12692277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 ORF57 promoter.
    Duan W; Wang S; Liu S; Wood C
    Arch Virol; 2001; 146(2):403-13. PubMed ID: 11315648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling.
    Zeng Y; Zhang X; Huang Z; Cheng L; Yao S; Qin D; Chen X; Tang Q; Lv Z; Zhang L; Lu C
    J Virol; 2007 Mar; 81(5):2401-17. PubMed ID: 17151125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 Long Terminal Repeat via the classical NF-kappaB pathway and functionally cooperates with Tat.
    Sun Q; Matta H; Chaudhary PM
    Retrovirology; 2005 Feb; 2():9. PubMed ID: 15713234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal in vitro interactions between human herpesvirus-6 and HIV-1 Tat.
    Di Luca D; Secchiero P; Bovenzi P; Rotola A; Caputo A; Monini P; Cassai E
    AIDS; 1991 Sep; 5(9):1095-8. PubMed ID: 1657039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression from the ORF50/K8 region of Kaposi's sarcoma-associated herpesvirus.
    Seaman WT; Ye D; Wang RX; Hale EE; Weisse M; Quinlivan EB
    Virology; 1999 Oct; 263(2):436-49. PubMed ID: 10544116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of human herpesvirus 8 open reading frame K5 independent of ORF50 expression.
    Okuno T; Jiang YB; Ueda K; Nishimura K; Tamura T; Yamanishi K
    Virus Res; 2002 Dec; 90(1-2):77-89. PubMed ID: 12457964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
    Chen H; He J; Fong S; Wilcox G; Wood C
    J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 ORF50 gene product contains a potent C-terminal activation domain which activates gene expression via a specific target sequence.
    Wang S; Liu S; Wu M; Geng Y; Wood C
    Arch Virol; 2001 Jul; 146(7):1415-26. PubMed ID: 11556717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular interactions between porcine and human gammaherpesviruses: implications for xenografts?
    Santoni F; Lindner I; Caselli E; Goltz M; Di Luca D; Ehlers B
    Xenotransplantation; 2006 Jul; 13(4):308-17. PubMed ID: 16768724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cells.
    Caselli E; Galvan M; Cassai E; Caruso A; Sighinolfi L; Di Luca D
    Blood; 2005 Oct; 106(8):2790-7. PubMed ID: 15976177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat.
    Guo HG; Pati S; Sadowska M; Charurat M; Reitz M
    J Virol; 2004 Sep; 78(17):9336-42. PubMed ID: 15308728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus through induction of KSHV Rta.
    Varthakavi V; Smith RM; Deng H; Sun R; Spearman P
    Virology; 2002 Jun; 297(2):270-80. PubMed ID: 12083825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein.
    Scala G; Ruocco MR; Ambrosino C; Mallardo M; Giordano V; Baldassarre F; Dragonetti E; Quinto I; Venuta S
    J Exp Med; 1994 Mar; 179(3):961-71. PubMed ID: 8113688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.